News

Biotech company Biogen (NASDAQ:BIIB) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.3% year on year to ...
Biogen’s second quarter delivered results that exceeded Wall Street’s revenue and profit expectations, a performance that was ...
ImmunityBio (IBRX) stock gains as its CAR-NK cell therapy shows promise in an early stage trial, with lymphoma patients ...
The First Trust Health Care AlphaDEX ETF (FXH) was launched on 05/08/2007, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Biogen CEO Chris Viehbacher says Novo Nordisk's Alzheimer's trial success could lead to combination therapies, boosting ...
With a market cap of $3.1 billion, Scholar Rock Holding Corporation appears fairly valued for now. Click here to read an ...
Major indices were in the green early on Wednesday, with the S&P 500 and Nasdaq Composite building on yesterday's ...
If you are shopping for a man who has everything, these are unique and unexpected ideas that will help you get over the gift ...